FINNENCE ▪ THE WIRE FILE

THE WIRE · № 57568

News■ Unclear/unknown

IPO Education Foundation Names Medtronic's Dr. William J. Peine as 2026 Inventor of the Year

2 SOURCES CONFIRMED · FIRST SEEN 2026-09-30 14:07 UTC

EXHIBIT · mmx.prnewswire.com

KINDNews

DIRECTION■ Unclear/unknown

SOURCES2

ENTITIES1

STORY SIZESTANDALONE

FIRST SEEN2026-09-30 14:07 UTC

LAST UPDATE2026-09-30 14:07 UTC

STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

An inventor award for a Medtronic executive is recognition, not a change in earnings or guidance.

Medtronic mention is incidental, not material

CATALYST TO WATCH

None; no product or financial disclosure

MAIN RISK

Reading company name as a catalyst

FULL DISPATCH

WASHINGTON, Sept. 30, 2026 /PRNewswire/ -- Intellectual Property Owners Education Foundation (IPOEF) announced that William J. Peine, Ph.D., Vice President of Research and Technology with the Surgical business of Medtronic, a global leader in healthcare technology, has been selected as...

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

CONTEXTHealthcare

04 RECEIPTS

THE SOURCE RECORD.

2 SOURCES CONFIRMED

№ 01googlenewsnews.google.com · CONFIRMING2026-09-30 14:07 UTCOPEN RECEIPT →

№ 02prnewswireprnewswire.com · PRIMARY2026-09-30 14:07 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

→CORRELATIONshares Healthcare
Merger Dominoes Fall as HealthPartners and Essentia Agree to Combine2026-09-30 14:08 UTC

→CORRELATIONshares Healthcare
Healthcare Data Monetization Market worth $1.3 billion by 20312026-09-30 14:30 UTC

→CORRELATIONshares Healthcare
New Biomarker Data Presented in a Late Breaking Oral Presentation at EADV Congress 2026 Showing Early Molecular Responses to Rezpegaldesleukin Across Multiple Immune Pathways Dysregulated in Patients with Atopic Dermatitis2026-09-30 14:30 UTC

→CORRELATIONshares Healthcare
Vasomotor Symptoms Market Poised for Growth Through 2036, Driven by Rising Adoption of Hormonal and Non-Hormonal Therapies2026-09-30 14:31 UTC

→CORRELATIONshares Healthcare
Signed and Scrubbed: September 2026 hospital M&A2026-09-30 14:58 UTC

←CORRELATIONshares Healthcare
New Phase 3 trial: SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight — Boehringer Ingelheim2026-09-30 12:00 UTC

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.